De Pardieu Brocas Maffei has advised UI Investissement on the entry of For Talents in Neftys Pharma’s capital. UI Investissement and Geneo Capital Entrepreneur have reinvested in connection with this new financing round. This transaction is intended to support the group’s family succession process and accelerate its growth strategy, particularly internationally.

Neftys Pharma is a French company specializing in the development, manufacturing, and commercialization of pharmaceutical products and medical devices. This transaction enables the group to rely on long-term financial partners sharing an entrepreneurial mindset and an ownership vision in the context of a family succession process.

For Talents is joining UI Investissement and Geneo Capital Entrepreneur as shareholders in Neftys Pharma to support the management team in pursuing and accelerating its development strategy, particularly internationally.